E2F3 and central nervous system cancer: E2F5, E2F7, and E2F8 were significantly upregulated in brain and CNS cancers relative to normal brain samples, while E2F1 and E2F3 were more highly expressed in normal brain samples in the ONCOMINE dataset (Supplementary Figure 2a).